DUBLIN--(BUSINESS WIRE)--The "Neuromodulation Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global neuromodulation market to grow with a CAGR of 10.9% over the forecast period of 2017-2023. The study on neuromodulation market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2015 to 2023.
The report on neuromodulation market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global neuromodulation market over the period of 2015 to 2023.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global neuromodulation market over the period of 2015 to 2023. Further, Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
- Deep Brain Stimulation
- Spinal Cord Stimulation
- Gastric Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Chronic Pain
- Parkinson's Disease
- Essential Tremor
- Obsessive Compulsive Disorder (OCD)
- Refractory Epilepsy
- Treatment Resistant Depression (TRD)
- Urinary Fecal Incontinence
- Other Applications
Key Topics Covered
2. Executive Summary
3. Global Neuromodulation Market Overview
4. Global Neuromodulation Market by Technology
5. Global Neuromodulation Market by Application
6. Global Neuromodulation Market by Region 2017-2023
7. Company Covered
- Medtronic plc
- Boston Scientific Corporation
- St. Jude Medical
- Cochlear Ltd.
- Advanced Bionics
- Sonova Group
- Nevro Corporation
- Neuronetics, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/zdzzh8/global?w=4